2.05 0 (0%) | 12-31 19:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 2.39 | 1-year : | 2.79 |
Resists | First : | 2.04 | Second : | 2.39 |
Pivot price | 2.04 | |||
Supports | First : | 2.03 | Second : | 2.02 |
MAs | MA(5) : | 2.04 | MA(20) : | 2.04 |
MA(100) : | 1.8 | MA(250) : | 1.84 | |
MACD | MACD : | 0 | Signal : | 0 |
%K %D | K(14,3) : | 100 | D(3) : | 100 |
RSI | RSI(14): 71.6 | |||
52-week | High : | 2.71 | Low : | 1.35 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ CSLT ] has closed below upper band by 40.2%. Bollinger Bands are 95.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 27 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | - | - |
Low: | - | - |
Close: | - | - |
Castlight Health, Inc. provides health navigation solutions for employers and health plan customers in education, manufacturing, retail, government, and technology industries in the United States. It provides Care Guidance Navigator that enables users to make better care decisions and navigate the employer-sponsored healthcare benefit programs; Wellbeing Navigator, which helps to drive engagement across an employer's benefits program; Complete Health Navigator that combines the Wellbeing Navigator and Care Guidance Navigator packages for unified user experience; and Castlight Care Guides, a high-touch navigation service. The company also offers white-labeled health navigation solutions and embedded platform technology services. In addition, it provides implementation and marketplace services. The company was formerly known as Ventana Health Services and changed its name to Castlight Health, Inc. in April 2010. Castlight Health, Inc. was incorporated in 2008 and is headquartered in San Francisco, California. As of February 16, 2022, Castlight Health, Inc. operates as a subsidiary of Vera Whole Health Inc..
Mon, 22 Jul 2024
Castlight: 4Q Earnings Snapshot - Yahoo Canada Sports
Thu, 17 Feb 2022
Vera Whole Health, Inc. Completes Acquisition of Castlight Health, Inc. - PR Newswire
Tue, 11 Jan 2022
Castlight Health and Vera Whole Health Transaction - William Blair
Fri, 07 Jan 2022
Castlight Health and Vera Whole Health Merge in $370M Deal - HIT Consultant
Wed, 05 Jan 2022
Castlight Health and Vera Whole Health to Combine to Pioneer and Scale Value-Based Care in Commercial Market - PR Newswire
Fri, 28 Aug 2020
Castlight Health (CSLT): Brian Marcotte Joins As New Advisor - Pulse 2.0
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
NYSE
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Healthcare Information Services
|
|
Shares Out | 135 (M) |
Shares Float | 122 (M) |
Held by Insiders | 4.8 (%) |
Held by Institutions | 74.4 (%) |
Shares Short | 2,450 (K) |
Shares Short P.Month | 2,980 (K) |
EPS | -0.06 |
EPS Est Next Qtrly | -0.04 |
EPS Est This Year | -0.24 |
EPS Est Next Year | -0.11 |
Book Value (p.s.) | 0.77 |
Profit Margin | -6.1 % |
Operating Margin | -7.1 % |
Return on Assets (ttm) | -3.8 % |
Return on Equity (ttm) | -7 % |
Qtrly Rev. Growth | -0.9 % |
Gross Profit (p.s.) | 0.69 |
Sales Per Share | 1.05 |
EBITDA (p.s.) | -0.03 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 21 (M) |
Levered Free Cash Flow | 25 (M) |
PE Ratio | -37.28 |
PEG Ratio | 0 |
Price to Book value | 2.62 |
Price to Sales | 1.94 |
Price to Cash Flow | 13.2 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |